Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Episurf Medical

0.08 SEK+0.66 %9.9. klo 18.29
Less than 1K followers

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+0.66 %
+18.94 %
-30.15 %
+53.54 %
+104.85 %
+96.38 %
-86.73 %
-96.56 %
-97.90 %

Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The company aims to create value growth through the acquisition and management of Nordic properties. The company also has a medical technology business based on the personalized implant Episealer® and associated surgical instruments, which are used to treat cartilage damage in joints. Episurf Medical's headquarters are located in Stockholm, Sweden.

Read more
Market cap
1.14B SEK
Turnover
1.21M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
20.11.
2026

Interim report Q3'26

26.2.
2027

Annual report '26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release07.09.2026 klo 16.47

Episurf Medical enters into letter of intent regarding acquisition of property in Greater Stockholm of approximately SEK 95 million

Episurf Medical
Press release03.09.2026 klo 11.40

Episurf Medical enters into a property management agreement with Newsec

Episurf Medical
Regulatory press release01.09.2026 klo 15.15

Episurf Medical enters the Finnish property market with the acquisition of logistics properties in the Helsinki area for EUR 33.6 mn

Episurf Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release31.08.2026 klo 12.55

The Board of Directors of Episurf has resolved on an issue of Class B shares and convertibles as part of the consideration for the acquisition of property assets

Episurf Medical
Regulatory press release24.08.2026 klo 09.00

Episurf Medical publishes interim report for January-June 2026

Episurf Medical
Regulatory press release22.08.2026 klo 21.00

Episurf accelerates its transformation into a pure-play property company and concludes the strategic review of the medtech operations

Episurf Medical
Regulatory press release20.08.2026 klo 08.25

Episurf Medical enters into a letter of intent regarding the acquisition of a property portfolio with an agreed property value of approximately SEK 505 mn

Episurf Medical
Regulatory press release19.08.2026 klo 22.39

Episurf Medical has entered into an agreement for the financing of the Lilium and Setune acquisitions and closing of the property acquisitions takes place on 31 August 2026

Episurf Medical
Regulatory press release01.08.2026 klo 10.45

Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release08.07.2026 klo 09.16

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of partial closing

Episurf Medical
Regulatory press release07.07.2026 klo 17.02

Episurf Medical completes the first partial closing of the portfolio announced on 5 June 2026, acquiring properties with an agreed property value of SEK 301 mn

Episurf Medical
Regulatory press release03.07.2026 klo 14.42

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of the consideration for the acquisition of property assets

Episurf Medical
Regulatory press release30.06.2026 klo 18.15

Correction: Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release30.06.2026 klo 17.15

Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release26.06.2026 klo 17.15

Episurf Medical has entered into a financing agreement for the KlaraBo acquisition and closing of the property portfolio takes place on 2 July 2026

Episurf Medical
Regulatory press release22.06.2026 klo 20.30

Episurf: Conversion of convertibles in a nominal amount of SEK 37,519,480 to 833,766,222 Class B shares

Episurf Medical
Regulatory press release10.06.2026 klo 14.34

Episurf Medical acquires Kuststaden Invest with a property portfolio at an agreed property value of SEK 647 mn

Episurf Medical
Regulatory press release05.06.2026 klo 17.30

Episurf Medical acquires a mixed property portfolio of 30 properties in Södermanland and Östergötland with an agreed property value of SEK 920 mn from Livi Fastigheter AB

Episurf Medical
Regulatory press release04.06.2026 klo 20.30

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertibles and warrants as part of the consideration for the acquisition of property assets

Episurf Medical
Regulatory press release29.05.2026 klo 16.44

Episurf Medical acquires a portfolio of four properties in Uppsala with an agreed property value of SEK 300 mn from Setune

Episurf Medical